Latest news
Verastem Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:04:15 GMTVerastem (VSTM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:40:10 GMTVerastem: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:19:19 GMTVerastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:01:00 GMTVerastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT